Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teenagers.
Michelle M. Maresca, MD
Advertisement
Michelle M. Maresca, MD, Medical Director for Pediatric Obesity Medicine, Joseph M. Sanzari Children's Hospital at Hackensack Meridian Hackensack University Medical Center.
Articles by Michelle M. Maresca, MD
Experts break down which labs actually change PMOS management and how to avoid diagnostic pitfalls.
Most patients meet PMOS in a primary care office first. Our experts map the referral threshold and argue insulin resistance — not just androgens — should drive how aggressively PCPs treat.
Our expert panel walks through the 2-criteria threshold for adolescents, the "at risk" category, and why untreated menstrual irregularity carries real long-term consequences.
A global consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.
Advertisement
Latest Updated Articles
The PMOS Diagnostic Workup: Labs, Rule-Outs, and Timing TipsSeptember 7th 2026
- From Primary Care to Specialist: Managing PMOS and Insulin Resistance
September 4th 2026
Advertisement
Advertisement
Trending on Patient Care Online
1
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
2
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
3
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
4
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
5